The effect of continuity of care on the incidence of end-stage renal disease in patients with newly detected type 2 diabetic nephropathy: a retrospective cohort study by �궓�젙紐� & 諛뺤�泥�
RESEARCH ARTICLE Open Access
The effect of continuity of care on the
incidence of end-stage renal disease in
patients with newly detected type 2
diabetic nephropathy: a retrospective
cohort study
Yun Jung Jang1,2†, Yoon Soo Choy3,4†, Chung Mo Nam5, Ki Tae Moon6 and Eun-Cheol Park4,5*
Abstract
Background: Diabetic nephropathy requires periodic monitoring, dietary modification, and early intervention to
prevent the disease severity within limited resource settings. To emphasize the importance of continuous care for
chronic diseases, various studies have focused on the association between continuity of care (COC) and common
adverse outcomes. However, studies aimed at understanding the effect of COC on the incidence of chronic diseases,
such as end-stage renal disease (ESRD), are few. The aim of this study was to determine whether there is an association
between COC and the incidence of ESRD among patients with diabetic nephropathy. Moreover, we identified
individual- and hospital-level factors associated with the incidence of ESRD among diabetic nephropathy patients.
Methods: We conducted a retrospective cohort study using the administrative National Health Insurance claims data
from 2005 to 2012 in the Republic of Korea. The dependent variable, a binary variable, was the incidence of ESRD due
to diabetic renal complication. In addition, using the COC index as a binary variable with a cutoff point of 0.75, we
divided patients into a ‘Good COC group’ (COC index≥0.75) and a ‘Bad COC group’ (COC index< 0.75). The survival
analysis was performed using the Cox proportional hazards models.
Results: Among 3565 diabetic renal complication patients, ESRD occurred among 83 diabetes mellitus patients (2.3%).
Nephropathy patients with lower COC level (< 0.75) had 1.99 times higher risk of ESRD incidence (95% confidence
interval [CI]:1.27–3.12). In addition, the lowest income level patients had higher hazard ratio (HR) of ESRD than the
highest income level patients (HR: 1.69 95% CI: 0.95–2.98), while patients with disabilities had 2.70 higher HR of ESRD
than patients without disabilities (95% CI: 0.64–43).
Conclusions: Among patients with diabetic renal complication, higher continuity of care was associated with lower
risk of ESRD. It is therefore recommended that continuous follow-up be encouraged to prevent ESRD among diabetic
renal complication patients. Moreover, disparities in health outcomes between socially vulnerable groups including
patients with disabilities and those in the lowest income level should be addressed.
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Background
Nephropathy causes approximately 48.0% of end-stage
renal disease (ESRD) cases, and accounts for an annual
medical cost of more than 1 billion dollars in the United
States [1]. The major complications of nephropathy,
which dramatically increase medical costs in the Repub-
lic of Korea, include kidney transplants, dialysis, percu-
taneous transluminal coronary angioplasty, coronary
artery bypass surgery, and leg amputation, according to
the stage of diabetic retinopathy and nephropathy [2].
Furthermore, in Korea, the number of patients with dia-
betes increased by 24.6% from 2010 to 2015, and among
them, approximately 5.8% were diagnosed with diabetic
renal complication [3, 4]. These diabetic complications
need periodic monitoring, dietary modification, and early
intervention. Therefore, to effectively manage chronic
diseases such as diabetes within limited resource
settings, policymakers have developed clinical practice
guidelines, with attention focused on the benefits of
continuity of care (COC) [5–7].
COC is an essential concept for high-quality patient
care, and it entails how patients’ experiences are linked
with care over time or the connectedness of the discrete
elements of care [8, 9]. Furthermore, COC has positive
effects on various outcomes; for example, it encourages
patient satisfaction, treatment adherence [10, 11], or in-
creases the recognition rate of diabetes, and leads to bet-
ter glycemic control among diabetic patients [12–16].
Moreover, higher COC with the usual provider for dia-
betes mellitus is associated with a lower risk of future or
preventable hospitalizations for long-term diabetic com-
plications, and it might further decrease medical costs
[17, 18]. Therefore, COC and management of the
physician-patient relationship should be reinforced in
the early stages of the disease condition for a more
effective management of diabetes [19].
Higher provider COC is characterized by better
approaches to the sharing of disease information, with-
out information asymmetry, while eliminating conflicts
of interest between patient and practitioners [20].
Despite evidence that COC is associated with better
patient outcomes, empirical studies of associations
between COC and health outcomes in the Korean popu-
lation are rare. Moreover, few studies exist on the effect
of COC on the incidence of other chronic diseases like
ESRD. Therefore, the aim of this study was to investigate
the association between continuity of ambulatory care
and the incidence of chronic kidney disease among
patients with renal diabetic complications, using the
administrative claims data from the Republic of Korea’s
National Health Insurance (NHI) scheme. Moreover, we
identified individual- and hospital-level factors associ-
ated with the incidence of ESRD among diabetic
nephropathy patients.
Methods
Data
A retrospective cohort study was conducted using
population-based data collated from the Korean NHI
database from 2005 to 2013. Data was obtained from the
Korean National Health Insurance Service-National
Sample Cohort (NHIS-NSC) claims database for 2002–
2012, which includes information on approximately 1
million Koreans since 2002. The NHIS-NSC used a 2.5%
(n = 1,025,340) stratified random sampling method, with
the goal of providing representative, useful health insur-
ance and health examination data to public health
researchers and policy makers. Of note, additional data
handling to account for missing data is unnecessary, as
the data was already processed by the NHIS upon
researcher request.
Based on the NHI data, newly diagnosed diabetic renal
complication (International Classification of Diseases
tenth edition diagnosis code (ICD-10): E11.2) patients
were identified. The data were also analyzed to deter-
mine the association between COC level and the inci-
dence of ESRD. The data were stratified according to
age, sex, region, health insurance type, disability status,
residence area, income decile, insulin treatment, and the
severity of complications. The data included participant
characteristics as well as medical institution variables
(hospital category, the number of beds, the number of
doctors, and hospital location) as covariates. All individ-
ual- and hospital-level characteristics were measured at
baseline in 2005. The diagnoses were based on the
ICD-10 codes.
Participants
The total number of individuals with diabetic nephropa-
thy (ICD-10: E11.2) was 4019 from 2002 to 2013. Of
these, 3706 patients were diagnosed in 2005, and to spe-
cifically analyze newly diagnosed diabetic nephropathy
patients, we excluded 130 prior diabetic nephropathy
patients and 11 prior ESRD patients from 2002 to 2004,
and included the first diabetic nephropathy
(ICD-10:E11.2) patient from 2005. Because we focused
on the continuity of ambulatory care for 8 years among
surviving diabetic nephropathy patients, and observed
the incidence of ESRD from 2005 to 2013, we excluded
47 patients who died during this period. Moreover, in
calculating COC index, we limited included patients to
those on hospital outpatient visits due to diabetic
nephropathy; hence, 245 inpatients and 21 health center
users were excluded. Using these criteria, the final study
sample included 3565 diabetic nephropathy patients.
The flow diagram of the study participants’ selection is
shown in Fig. 1. Furthermore, to perform survival ana-
lysis using a Cox proportional hazards models, we chose
an appropriate follow-up period. In patients diagnosed
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with ESRD, we set the follow-up period as the time from
the start date to the date of ESRD occurrence. On the
other hand, we set the end date as the death date or the
end of 2013 for the non-ESRD group and deceased
patients.
Independent variable: COC
COC was included as an independent variable, and
included both prescription continuity and the clinical
management of diseases. Moreover, the measurement of
COC considered the characteristics of the Korean medial
delivery system, where patients are allowed to freely
choose their preferred primary care. Therefore, the COC
index was chosen to measure consistency of care.
According to the findings of previous studies, COC
can be determined in many ways, including the use of
the Modified Continuity Index, and the Most Frequent
Provider Continuity [21–25].
As devised by Bice et al. (1977), the COC index can be
calculated by the total patient contact times with the
medical service providers and the number of healthcare
providers. The COC index ranges from 0 (when patients’
visits to medical institutions occur with different pro-
viders at each visit) to 1 (when patients present to the
same medical institution for outpatient services on many
occasions). Therefore, an index close to 1 implies that
the patient frequently utilizes a particular medical
service provider; hence, the COC level is high.
The formula for determining the COC index is shown
below:
COC ¼
XM
j¼1
n2j−N
N N−1ð Þ
Where N = the total number of visits, M = the number
of available medical service providers, and nj = the num-
ber of visits to the jth providers.
From previous studies [26, 27], we used the cutoff
point of 0.75 for the COC index, whereby patients were
classified as having good COC if they had 75% of their
ambulatory visits with the same practitioner over the
study period. On the other hand, patients who made less
than 75% of visits to the same doctor were classified as
having bad COC. This measure has been validated
extensively in previous studies. Therefore, we used the
COC index because the caregivers are not determined in
advance in Korea, and we calculated patients’ visits until
the occurrence of ESRD. Furthermore, the number of
days from the first diagnosis to ESRD occurrence was
calculated. The COC index was categorized as a binary
variable into the ‘Good COC group’ (COC index≥0.75),
when diabetic patients most often visited the same med-
ical institutions for the treatment of diabetic complica-
tions, and the ‘Bad COC group’ (COC index< 0.75),
when diabetic patients visited different medical institu-
tions on most occasions, similar to the findings of previ-
ous studies [28, 29].
Dependent variable: The incidence of ESRD
In this study, the dependent variable was the incidence of
ESRD. To measure this, we identified patients who devel-
oped ESRD using ICD-10 codes such as hemodialysis
(O7020, O9991), peritoneal dialysis (O7062), or kidney
transplant (R3280), among newly diagnosed patients with
diabetic renal complications from 2005 to 2012.
Covariates
We examined covariates that affected the occurrence of
ESRD and the COC of patients with diabetic renal
complications. Furthermore, we included both individ-
ual- and hospital-level characteristics as covariates.
Individual-level characteristics adjusted for included sex,
age, residence area, health insurance type, income level,
insulin treatment, disability status, and disease severity.
Age was categorized into five groups (under 50, 50–59,
60–69, 70–79, and over 80 years). Residence area was
divided into three groups (metropolitan, urban, and rural
areas). Health insurance type was categorized as health
insurer and Medicaid user. Furthermore, we divided in-
come into four quartiles of 25% each, from the lowest
(Q1) to the highest (Q4).
Fig. 1 Flow diagram of study participants
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Disease severity was measured by the Korean
Diagnosis-Related Group (KDRG) codes and comorbidi-
ties. Related with diabetes mellitus were six-digit KDRG
codes including K60000, K60001, K60002, and K60003.
Among the numbers, the last digits (0, 1, 2, and 3)
represent the Patient Clinical Complexity Level (PCCL).
By definition, ‘0’ implies without severe status or comor-
bidity, ‘1’ indicates the presence of accompanying
mid-level complications or comorbidities, ‘2’ refers to the
presence of more severe complications or comorbidities,
while ‘3’ implies the most severe complications or
comorbidities. The increasing severity implies that the
larger the number, the higher the severity of the disease.
Furthermore, PCCL was defined as the severity value
according to the number of complications related to dia-
betes mellitus using the KDRG codes.
Moreover, we adjusted for both hospital- and
individual-level characteristics. We included hospital
classifications (general hospital, hospital, and clinic),
categorized according to the Korean medical law. Based
on hospital organization type, acute care hospitals were
included in ‘hospitals’, while ‘general hospitals’ were
defined by The Korean Hospital Association as hospitals
with 80 or more beds and at least eight major clinical
departments. Such clinical departments include internal
medicine, general surgery, pediatrics, obstetrics and
gynecology, radiology, emergency medicine, and path-
ology. Moreover, number of beds, number of doctors,
and hospital location (metropolitan, urban, rural) were
included as covariates. The capital and largest city
(“Seoul”) was included in “Metropolitan area,” while
“Urban” was defined as cities classified by administrative
districts (such as Busan, Daegu, Incheon, Gwangju,
Daejeon, and Ulsan). For both the number of beds and
the number of doctors, the medians were reported; all of
these covariates and all diagnostic information were
collected at baseline (2005).
Statistical analysis: Survival analysis
For this study, we used SAS version 9.4 (SAS institute
Inc. Cary NC, USA) statistical software and the signifi-
cance level was set at 5%. First, the distribution of demo-
graphic characteristics among diabetic patients with
renal complications were assessed at baseline. Baseline
categorical variables were expressed as numbers and
percentages and were compared using the χ2 test.
Second, survival analysis was performed to determine
the effect of COC on the incidence of ESRD among
diabetic patients with renal complications using the Cox
proportional hazards models. Furthermore, the
Kaplan-Meier curve was plotted to demonstrate the es-
sential assumption of proportional hazard regression
model. Moreover, we calculated the mean time to the
diagnosis of ESRD by each categorical variable using the
log-rank test. The adjusted hazard ratios (HRs) for the
incidence of ESRD by the Cox proportional hazards
models were calculated using the PROC PHREG proced-
ure in SAS. Third, after adjusting for other individual-
and hospital-level characteristics on the regression
model, we conducted subgroup analysis to determine
the association between COC and the incidence of ESRD
by residence area, income level, and disability to determine
the effect of socio-economic status on patients’ COC.
Results
Demographic characteristics of the study population
A total of 3565 patients with the diagnosis of
non-insulin-dependent diabetes mellitus with renal com-
plications were included in this retrospective cohort
study from 2005 to 2012. Table 1 presents the demo-
graphic characteristics of the study population at base-
line (2005). To calculate the COC index, we defined the
time period as the time from when a diabetic nephropa-
thy patient started using hospital ambulatory care to the
event time, whether ESRD was diagnosed or not, by the
end of follow-up. During the 8-year follow-up from 2005
to 2012, 83 patients were diagnosed with ESRD with a
mean ± standard deviation (SD) COC level of 0.398 ±
0.492. Among the 3482 patients with no ESRD, the
mean ± SD COC level was 0.612 ± 0.487.
Until 2012, among the 83 of 3565 diabetic nephropathy
patients who developed ESRD, the overall incidence of
ESRD was 520.4 per 100,000 person-years (95% confidence
interval (CI) 419.7–645.4 per 100,000 person-years), and
332.4 and 830.4 per 100,000 person-years for the Good and
Bad COC, respectively. The comparison of subject’s base-
line characteristics showed that ‘Bad COC’ had higher inci-
dence of ESRD than Good COC.
Survival analysis for the incidence of ESRD using Kaplan-
Meier curve
Fig. 2 shows the Kaplan-Meier curve of the incidence
probability of ESRD by independent variables among the
‘Good’ and ‘Bad’ COC groups. According to the curve,
those in the ‘Good COC group’ had lower incidence
probability than those in the ‘Bad COC group’, and, with
time, the incidence probabilities in both groups became
sustained. Moreover, the median time of survival for
individuals with Good and Bad COC were 4.58 and
4.30 years, respectively, in the Kaplan-Meier analysis.
Cox proportional hazard model showing association
between continuity of care and the incidence of end-
stage renal disease
Table 2 shows the results of the Cox proportional haz-
ards models showing the association between COC and
the incidence of ESRD among diabetic patients with
renal complications. After adjusting for all covariates
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Table 1 Distribution of subject characteristics by ESRD occurrence at baseline 2005
Total ESRD occurrence Person-year Incidence Rate
(×10−5)
p-value
Yes No
Patient level
Sex
Male 1937 44 (2.3) 1893 (97.7) 8597.9 511.8 0.81
Female 1628 39 (2.4) 1589 (97.6) 7350.2 530.6
Age (years)
Under 50 738 9 (1.2) 729 (95.0) 3625.3 248.3 0.16
50–59 926 24 (2.6) 902 (94.1) 4169.8 575.6
60–69 1097 26 (2.4) 1071 (93.4) 4958.0 524.4
70–79 666 20 (3.0) 646 (93.2) 2665.8 750.2
80 and more 138 4 (2.9) 134 (94.2) 529.1 755.9
Residence area
Metropolitan 829 18 (2.2) 811 (97.8) 3849.9 467.5 0.52
Urban 883 17 (1.9) 866 (98.1) 4105.7 414.1
Rural 1853 48 (2.6) 1805 (97.4) 7992.4 600.6
Health insurance type
Health insurance 3471 80 (2.3) 3391 (97.7) 15,694.6 509.7 0.59
Medical aid 94 3 (3.2) 91 (96.8) 253.5 1183.2
Income
Q1 (Low) 816 27 (3.3) 789 (96.7) 3360.8 803.4 0.16
Q2 747 12 (1.6) 735 (98.4) 3361.4 357.0
Q3 787 18 (2.3) 769 (97.7) 3694.2 487.2
Q4 (High) 1215 26 (2.1) 1189 (97.9) 5531.7 470.0
Insulin treatment
Yes 160 3 (1.9) 157 (98.1) 15,312.6 522.4 0.69
No 3405 80 (2.4) 3325 (97.7) 635.5 472.1
Disabled type
Yes 482 28 (5.8) 454 (94.2) 1919.1 1459.0 <.0001
No 3083 55 (1.8) 3028 (98.2) 14,028.9 392.0
PCCL indexb
0 3469 80 (2.4) 3389 (97.6) 15,722.7 521.5 0.23
1 61 2 (3.3) 59 (96.7) 131.5 1521.4
≥2 35 1 (4.2) 34 (97.1) 93.9 1064.9
Continuity of carea
Good (0.75≤ COC index) 2164 33 (1.5) 2131 (98.5) 9926.7 332.4 <.0001
Bad (COC index< 0.75) 1401 50 (3.6) 1351 (96.4) 6021.4 830.4
Hospital level
Hospital classification
General hospital 2040 52 (3.5) 1968 (96.5) 9266.5 777.0 <.0001
Hospital 97 11 (11.0) 86 (89.0) 408.1 245.1
Clinic 1428 20 (1.4) 1408 (98.6) 6273.5 159.4
Number of beds 787.5 ± 461.0 475.7 ± 508.6 <.0001
Number of doctors 220.2 ± 164.3 136.2 ± 194.0 <.0001
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(individual- and hospital-level characteristics), ne-
phropathy patients with Bad COC had 1.99 times
higher risk of ESRD incidence (95% CI: 1.27–3.12).
We also implemented sensitivity analysis, which
included 47 study participants who had died, and the
results were similar to those in Table 2 (see
Additional file 1: Table S1).
In Additional file 1: Table S1, factors associated with
ESRD incidence are shown. Among individual-level
characteristics, some variables were associated with
ESRD incidence. The female sex showed a hazard ratio
(HR) of 1.06, which was higher than that of males, while
patients above 50 had higher probability of ESRD than
those under 50. Patients who lived in rural (HR: 0.84
Table 1 Distribution of subject characteristics by ESRD occurrence at baseline 2005 (Continued)
Total ESRD occurrence Person-year Incidence Rate
(×10−5)
p-value
Yes No
Location
Metropolitan 973 19 (2.0) 954 (7.5) 4608.6 412.3 0.63
Urban 1016 24 (2.4) 992 (6.5) 4681.2 512.7
Rural 1576 40 (2.5) 1536 (5.3) 6658.3 600.8
Survey Year
2005 587 15 (2.5) 572 (97.5) 4975.1 301.5 0.36
2006 440 5 (1.1) 435 (98.9) 2797.6 178.7
2007 493 10 (2.0) 483 (98.0) 2611.7 382.9
2008 526 12 (2.3) 514 (97.7) 2278.4 526.7
2009 544 17 (3.1) 527 (96.9) 1797.4 945.8
2010 457 14 (3.1) 443 (96.9) 1073.1 1304.6
2011 255 8 (3.1) 247 (96.9) 343.7 2327.4
2012 263 2 (3.8) 261 (96.2) 71.0 2817.8
Total 3565 83 (2.3) 3482 (97.7)
aCOC index ranges from 0 to 1; 1 means that one patient has visited only one physician, and we could not put other continuity indices in this model at the same
time because of multicollinearity among indices; Good is defined as COC score greater than 0.75, and Bad is defined as COC score less than 0.75
bThe larger value was used regardless of whether the number of complications was related to diabetes mellitus or PCCL (Patient Clinical Complexity Level) using
the KDRG code
Fig. 2 the Kaplan-Meier curve of the incidence probability of ESRD by divided COC groups and legend for exposure categories outcome with p-
value for log-rank test
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95% CI: 0.41–1.70), or urban areas (HR: 0.50 95% CI:
0.19–1.34) had lower incidence probability of ESRD than
metropolitan citizens. In addition, those in the lowest
income group had higher probability of developing renal
failure than patients in the highest income group (HR:
1.69 95% CI: 0.95–2.98). However, none of these findings
were statistically significant. Similarly, although patients
with disabilities had higher ESRD incidence (2.70) than
patients without disabilities, no significant difference
(95% CI: 0.64–43) was found.
Among hospital-level characteristics, patients who
utilized hospitals with either the highest number of beds
or doctors had the highest probability of ESRD. Further-
more, when the hospital was located in a rural or urban
area, the probability was also higher; however, these
findings were not statistically significant. In addition,
primary care level attendance showed a lower hazard
(0.48) of ESRD than with general hospital attendance,
with no statistically significant association (95% CI:
0.20–1.14).
Subgroup analysis: Association between COC and the
incidence of ESRD by residence area, income level, and
disability
In Table 3, the results of the subgroup analysis of the
association between continuity of care with and occur-
rence of ESRD occurrence by residence area, income,
disability type, sex, and health insurance type are shown.
After building the model adjusted for other individual-
and hospital-level characteristics such as sex, age, health
insurance type, hospital categories, number of doctors,
number of beds, and hospital location, we conducted
subgroup analysis to determine the association between
COC and the incidence of ESRD by residence area,
income level, disability type, sex, and health insurance
type (Table 3).
Among patients with renal diabetic complications liv-
ing in metropolitan areas, those with ‘Bad’ COC index
(< 0.75) had 2.11 times higher probability of developing
ESRD (95% CI: 1.04–5.30), and this was similar to the
finding among patients living in rural areas (HR: 1.92,
95% CI: 1.06–3.48) or urban areas. However, in urban
areas, no significant association was observed between
COC and the incidence of ESRD.
Furthermore, among patients with diabetic complica-
tion in the lowest (Q1), second lowest (Q2), and the
highest income levels, hospital medical services were
more poorly utilized, the incidence probability was
increased, and these associations were statistically sig-
nificant. Moreover, patients with disabilities in the
‘Good’ COC group had a lower probability of ESRD
compared with the ‘Bad’ COC group, with 1.86 higher
incidence probability of ESRD (95% CI: 1.07–3.26).
Among hospital factors, hospitals in rural areas had a
lower probability of ESRD for the ‘Good’ COC group
than the ‘Bad’ COC group, with 2.05 higher incidence
probability of ESRD (95% CI: 1.09–3.85). In addition,
hospital classification was associated with the relation-
ship between COC and the occurrence of ESRD. How-
ever, no significant association was observed between
COC and the incidence of ESRD in hospitals and clinics.
Discussion
According to findings of a previous study, COC consists
of various elements not only the service provider and
patient relationship, but also continuous data accessibil-
ity or total care management, which meant coherent
delivery of care from different doctors [30]. Although
COC is a complex concept, the core component is the
consistency of contacts between specific patients and the
providers [31]. Moreover, according to previous studies,
the higher the severity or number of diabetic complica-
tions, the higher the probability of adverse patient out-
comes, such as mortality and hospitalizations; therefore,
there is need for consistency in the care of diabetic
patients [32, 33]. In addition, newly diagnosed patients
with hypertension, diabetes, hyperlipidemia, and those
with bad COC levels, have higher risks of heart attack
and cardiovascular heart diseases than patients with
good COC levels [34].
The results of this study demonstrate that good COC
in patients with diabetic renal complications is signifi-
cantly associated with a lower probability of ESRD.
Subgroup analysis was performed to determine whether
there is an association between COC and ESRD by resi-
dence area, income level, and disability, revealing a
higher probability of ESRD among patients with bad
COC index (< 0.75) who lived in metropolitan and rural
areas. Moreover, diabetic patients (who either had
disabilities or were in the lowest income level) with bad
COC level had higher probability of ESRD, but there
was no statistically significant association with these
variables.
According to the findings of this study, the association
between COC for diabetic complications and the prob-
ability of developing ESRD is consistent with the
Table 2 Association between continuity of care and ESRD
incidence*
ESRD incidence
Hazard Ratio 95% CI
Continuity of care
Good (COC index≥0.75) 1.00 – –
Bad (COC index< 0.75) 1.99 (1.27 – 3.12)
*Adjusted for sex, age, residence area, health insurance type, disability type,
insulin treatment, PCCL index, hospital classification, number of beds, number
of doctors, and hospital location
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Table 3 Subgroup analysis for the association continuity of care with occurrence of secondary diabetic complication by patient-
level and hospital-level factors
Continuity of care p-value
Good (0.75≤ COC index) Bad (COC index < 0.75)
Hazard ratio (Ref.) Hazard ratio 95% CI
ESRD incidence
Patient-level
Sex
Male 1.00 2.04 (1.09 – 3.82) 0.03
Female 1.00 1.86 (0.96 – 3.60) 0.07
Age
Under 50 1.00 3.00 (0.75 – 11.98) 0.12
50–59 1.00 3.83 (0.36 – 1.95) 0.83
60–69 1.00 4.24 (1.78 – 10.09) 0.00
70–79 1.00 4.39 (1.59 – 12.07) 0.00
80 and more 1.00 1.41 (0.20 – 10.01) 0.73
Residence area
Metropolitan 1.00 2.11 (1.04 – 5.30) 0.04
Urban 1.00 1.70 (0.62 – 4.65) 0.24
Rural 1.00 1.92 (1.06 – 3.48) 0.04
Health insurance type
Health insurance 1.00 1.91 (1.21 – 3.03) 0.01
Medical aid 1.00 1.93 (0.17 – 21.57) 0.59
Income
Q1 (Low) 1.00 2.04 (0.92 – 4.52) 0.08
Q2 1.00 1.70 (1.38 – 4.82) 0.02
Q3 1.00 0.94 (0.36 – 2.45) 0.91
Q4 (High) 1.00 2.27 (1.01 – 5.14) 0.05
Disabled type
Yes 1.00 2.08 (0.96 – 4.48) 0.06
No 1.00 2.23 (1.43 – 3.49) 0.00
Hospital-level
Hospital classification
General hospital 1.00 1.86 (1.15 – 2.99) 0.01
Hospital 1.00 2.11 (0.64 – 6.91) 0.22
Clinic 1.00 2.73 (0.79 – 9.42) 0.11
Number of beds
Q1 (Low) 1.00 2.60 (1.03 – 6.59) 0.04
Q2 1.00 1.39 (0.54 – 3.60) 0.50
Q3 (High) 1.00 2.00 (1.11 – 3.61) 0.02
Number of doctors
Q1 (Low) 1.00 1.99 (0.72 – 5.48) 0.18
Q2 1.00 1.87 (0.67 – 5.25) 0.24
Q3 (High) 1.00 1.86 (1.06 – 3.27) 0.03
Location
Metropolitan 1.00 1.96 (0.79 – 4.86) 0.15
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findings of previous studies, which emphasized that the
better the COC, the better the outcome of various
chronic conditions. Liao et al. revealed that diabetes
mellitus patients with a high medical care-seeking
consistency with a physician had a lower risk of diabetic
complications compared with patients having a medium
or low medical care-seeking consistency [35]. Christakis
et al. further emphasized that children with a medium
or high COC were less likely to be hospitalized for dia-
betic ketoacidosis [36]. Another study revealed that
consistency in diabetic care increases patient satisfaction
and decreases the risk of other chronic diseases [37].
The benefits of COC are enhanced among chronic dis-
ease patients because they tend to demand treatment
more consistently than others without chronic diseases,
who tend to engage in passive medical services
utilization. Thus, the physician-patient relationship
might be improved. Furthermore, improved COC was
associated with a reduction in all-cause mortality, and
prevented hospitalizations as reported in previous
studies [38, 39].
The findings of our study indicate that improved COC
among patients with nephropathy is associated with a
lower probability of ESRD. Based on the patients’ socio-
economic statuses, some distinctions were observed
among the variables. Specifically, with patients who lived
in rural areas, the COC level was lower than that of
those living in urban areas. In addition, based on the
hospital characteristics, patients tend to visit clinics
rather than general hospitals or hospitals, and so the
COC index was higher among clinic users. The gap in
the COC level influenced the probability of ESRD. Ac-
cording to our findings, patients who used medical ser-
vices consistently had lower probability of ESRD than
patients with lower COC index. This is consistent with
the findings of previous studies, which emphasized on
the importance of continuous diabetic care to prevent
future hospitalizations, mortality, and excessive medical
expenses. Furthermore, patients who used clinics for the
care of diabetes had a lower probability of ESRD than
patients who visited general hospitals [40, 41].
Among other characteristics, including the lowest
income, and elderly patients, higher probability of ESRD
was reported; in particular, patients with disabilities had
much higher probability of ESRD than those without
disabilities. However, there was no statistically significant
difference in the COC among patients with disabilities.
As shown in the subgroup analysis, patients who lived
in rural areas with worse COC had higher probability of
ESRD. Although there was no difference by location in
the subgroup analysis, in both regions the continuity of
diabetic care among nephropathy patients was important
to prevent future ESRD. Additionally, except for
mid-high income level (Q3), improved COC level af-
fected the probability of ESRD, and although this was
not statistically significant, patients with bad COC levels
had higher probability of ESRD. A similar trend was also
observed for patients with disabilities and other covari-
ates. With disability status, the proportion of ESRD was
higher in patients with disabilities and those with the
lowest income level. Although the socioeconomic status
showed no direct effect on the probability of ESRD, and
there was no significant gap in the consistency of
diabetic care, there might be underlying disparities in
the care of patients who are socially vulnerable, such as
patients with disabilities or those in the lowest income
level. Hence, these subgroups of patients should be
aware of how to prevent the occurrence of ESRD. This
is similar to the explanations from previous studies,
which emphasized that poorer access to health care
among black patients might explain their excess risk of
ESRD, beyond the excess risk explained by demographic,
socioeconomic, lifestyle, and clinical factors [42–45].
However, our study demonstrated the effect of COC on
the probability of ESRD, and showed that patients with
nephropathy (patients with renal complication) with bad
COC level had higher probability of ESRD. In future re-
search, the effect of COC on the actual change in clinical
parameters, such as glycemic control, should be imple-
mented to emphasize the importance of continuous care.
Moreover, policy development to encourage COC
among patients with diabetic complications, aimed at
preventing severe chronic disease and managing diabetic
complications more effectively in the future, should be
implemented. There is need for further research aimed
at minimizing the probability of ESRD among vulnerable
classes of patients, among whom access to care is more
difficult [46].
Our study has some limitations. First, we only used
the procedure codes and ICD-10 codes from NHI claim
Table 3 Subgroup analysis for the association continuity of care with occurrence of secondary diabetic complication by patient-
level and hospital-level factors (Continued)
Continuity of care p-value
Good (0.75≤ COC index) Bad (COC index < 0.75)
Hazard ratio (Ref.) Hazard ratio 95% CI
Urban 1.00 3.46 (1.52 – 7.91) 0.00
Rural 1.00 2.05 (1.09 – 3.85) 0.03
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data for defining ESRD. The procedures included
hemodialysis, peritoneal dialysis, and kidney transplant.
However, ESRD could be divided into several stages
based on the disease severity while other clinical proce-
dures could be used for defining ESRD. Hence, we might
have underestimated the number of ESRD patients in
our study. However, we defined ESRD by ICD-10 codes
that were implemented for improving kidney functions;
hence, the findings of our study showed that better
consistency in diabetic nephropathy care resulted in a
lower probability of ESRD.
Second, since we conducted a retrospective cohort
study, with the exposure categorized as a dichotomous
variable, misclassification was inherent. In cohort studies,
exposure misclassification commonly occurs. If the assess-
ment of exposure is implemented independently of the
disease diagnosis, misclassification tends to result in spuri-
ous conclusion. Furthermore, not only with the exposure
but also with certain covariates, using administrative data
usually leads to misclassifications. Minimizing misclassifi-
cation in future research should be ensured.
The third limitation is the lack of information on
health behaviors such as perceived health status, smok-
ing, depression, and drinking status, which might affect
the incidence of ESRD. Health behaviors and blood
glucose control are highly correlated, as revealed by
findings of previous studies. Due to unmeasured or un-
known factors, which might act as effect modifiers for
the outcome (ESRD incidence), residual confounding
might exist in this study, and this might have resulted in
an imperfect adjustment, or could have led to spurious
conclusions. To minimize this limitation, propensity
score methods for determining the appropriate covari-
ates to adjust for in the analysis should be applied in
future research.
Moreover, we did not include hospital or doctor char-
acteristics that might have had an influence on the prob-
ability of ESRD. In addition, we could not explain how
the severity of diabetic renal complications affected the
probability of ESRD, and with the limited data, we were
unable to investigate whether study patients used out-
patient prescriptions that might also have had an effect
on the progression of ESRD. Furthermore, since the
cause of death was not included in the health insurance
qualification database, we could not clarify whether pa-
tients died as a result of diabetic complication or not.
Since our focus was on the association between continu-
ity of ambulatory care and the incidence of ESRD during
the 8-year follow-up, we limited the analysis to survivals
during follow-up period. Therefore, the number of
patients might have been underestimated in this study.
The fourth limitation is that we did not evaluate the
COC in multiple ways. We focused on the COC based
on the COC index alone. However, there are several
other indices such as the Usual Provider Care index and
the Sequential Continuity of Care index; hence, we were
unable to explain which COC index might explain the
probability of ESRD better. Moreover, despite our inclu-
sion of the patients’ individual- and hospital-level char-
acteristics as covariates in the main analysis, we failed to
test for correlations within hospitals. Since we only
determined the association of COC among diabetic
nephropathy patients, further research should be imple-
mented to also assess the correlation within hospitals
among the care episodes.
Furthermore, because of inappropriate handling of
missing data, there is a potential of the effect estimate
(HR) to be biased towards the null. Since we determined
the association between COC and the incidence of ESRD
among survivors during the 8-year follow-up, the exclu-
sion of patients who died tends to underestimate the
number of diabetic nephropathy patients. Furthermore,
we excluded inpatients or health center users. To assess
the effect of the COC on the incidence of ESRD, all out-
patient medical use history should be included. To
minimize potential selection bias, more refined sampling
methods are needed, such as matching, or including the
appropriate control group.
Despite these limitations, our study has several
strengths. First, we analyzed a representative sample of pa-
tients with diabetic renal complications using nationwide
claims data in Korea. Secondly, unlike most previous stud-
ies, we included each patient’s socioeconomic status,
which could define the difference in COC between socially
vulnerable patients, including patients with lower income
level, or those with or without disabilities.
Our results support the hypothesis that reducing frag-
mented care and improving COC among diabetic com-
plication patients can decrease the probability of ESRD.
We therefore encourage policymakers to recognize the
need for an effective healthcare delivery system that pro-
motes COC. Furthermore, to enhance accessibility, we
suggest the need to undertake studies aimed at examin-
ing the relationship between medical service providers
and patients with diabetic complications. In addition, to
prevent the progression of ESRD among patients with
type 2 diabetes mellitus with renal complications, it is
necessary to undertake measures aimed at improving the
sustainability of patients with disabilities. Continuous
efforts of medical staff and changes in the national pol-
icy for chronic disease management are necessary to im-
prove outpatient care for the sustainable use by patients.
Conclusion
In conclusion, we measured COC among newly diag-
nosed nephropathy patients during the entire study
period and analyzed the relationship between the COC
and the probability of ESRD. According to our results,
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higher continuity of care was associated with lower risk of
ESRD among patients with diabetic renal complication.
To prevent ESRD among diabetic renal complication pa-
tients, continuous follow-up should be encouraged. More-
over, there were disparities in health outcomes between
socially vulnerable groups. To bridge the gap in health
outcomes among the different socio-economic patient
groups, accessibility of care without disparities should be
guaranteed. Further research is needed on the associations
between long-term COC and various healthcare out-
comes, including medical expenses or patient’s quality of
life. Moreover, to ensure that the study findings could be
generalized to the larger population of patients, long-term
follow-up of patients with diabetic complications would
be needed. Health behavior, changes in the socioeconomic
status, and disease progression mechanisms, which might
mediate the utilization of medical services and health out-
comes, should be considered.
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